Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Am J Surg. 2019 Sep 17;219(3):492–495. doi: 10.1016/j.amjsurg.2019.09.013

Figure 1. Urinary TIMP-1 and LYVE-1.

Figure 1.

Figure 1.

A) Normalized urinary TIMP-1 levels in healthy, low/moderate-grade IPMN, high-grade/invasive IPMN and PDAC are shown in the scatter plot (horizontal lines - median, interquartile range). B) Normalized urinary LYVE-1 levels in healthy, chronic pancreatitis (CP), low/moderate-grade IPMN, high-grade/invasive IPMN and PDAC groups are shown in the scatter plot. Statistically significant differences between groups are indicated; no significant differences were detected between low/moderate and high/invasive grades of IPMN.